# Vera Bittner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vera-bittner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,335 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 97 |
| i10-index | 316 |
| Last Known Institution | University of Alabama at Birmingham |
| OpenAlex ID | https://openalex.org/A5048484359 |
| ORCID iD | https://orcid.org/0000-0001-9456-850X |
| Works | 624 |

## Researcher papers

- [Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome](https://scholariq.org/papers/alirocumab-and-cardiovascular-outcomes-after-acute-coronary-syndrome/)
- [Exercise Standards for Testing and Training](https://scholariq.org/papers/exercise-standards-for-testing-and-training/)
- [Triglycerides and Cardiovascular Disease](https://scholariq.org/papers/triglycerides-and-cardiovascular-disease/)
- [2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines](https://scholariq.org/papers/2023-aha-acc-accp-aspc-nla-pcna-guideline-for-the-management-of-patients-with/)
- [Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study](https://scholariq.org/papers/insights-from-the-nhlbi-sponsored-women-s-ischemia-syndrome-evaluation-wise/)
- [Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study](https://scholariq.org/papers/insights-from-the-nhlbi-sponsored-women-s-ischemia-syndrome-evaluation-wise-2/)
- [Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women](https://scholariq.org/papers/effects-of-hormone-replacement-therapy-and-antioxidant-vitamin-supplements-on/)
- [2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease](https://scholariq.org/papers/2023-aha-acc-accp-aspc-nla-pcna-guideline-for-the-management-of-patients-with-2/)
- [Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial](https://scholariq.org/papers/effect-of-alirocumab-a-monoclonal-antibody-to-pcsk9-on-long-term-cardiovascular/)
- [Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial](https://scholariq.org/papers/effects-of-alirocumab-on-cardiovascular-and-metabolic-outcomes-after-acute/)
- [Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure](https://scholariq.org/papers/effects-of-right-ventricular-ejection-fraction-on-outcomes-in-chronic-systolic/)
- [Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists](https://scholariq.org/papers/clinical-utility-of-inflammatory-markers-and-advanced-lipoprotein-testing-advice/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Cardiac Health and Mental Health](https://scholariq.org/topics/cardiac-health-and-mental-health/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [University of Alabama at Birmingham](https://scholariq.org/institutions/university-of-alabama-at-birmingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.